| Foreside Behavior Associates | |
|
1321 Washington Ave Ste 302 Portland ME 04103-3675 | |
| (207) 613-7324 | |
| (207) 613-7333 |
| Full Name | Foreside Behavior Associates |
|---|---|
| Speciality | Psychologist |
| Location | 1321 Washington Ave Ste 302, Portland, Maine |
| Authorized Official Name and Position | Susan Jarmuz-smith (CLINICAL DIRECTOR) |
| Authorized Official Contact | 2076137324 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Foreside Behavior Associates 1321 Washington Ave Ste 302 Portland ME 04103-3675 Ph: (207) 613-7324 | Foreside Behavior Associates 1321 Washington Ave Ste 302 Portland ME 04103-3675 Ph: (207) 613-7324 |
| NPI Number | 1982076485 |
|---|---|
| Provider Enumeration Date | 10/22/2015 |
| Last Update Date | 11/23/2022 |
| Certification Date | 11/23/2022 |
| Medicare PECOS PAC ID | 0941581664 |
|---|---|
| Medicare Enrollment ID | O20170206000593 |
News Archive
A new study by researchers at NYU Langone Medical Center reveals that the presence of Helicobacter pylori (H. pylori) bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes.
Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.
The ability of the brain to synchronize with the tone and intonation of speech influences how language is processed. This concludes a study by the Basque research center BCBL, whose results could help design more effective activities to train the brain in order to avoid future disorders such as dyslexia.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982076485 | NPI | - | NPPES |
| 1164824082 | Other | NPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Secondary |
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Susan Lynn Jarmuz-smith |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1164824082 PECOS PAC ID: 3678854395 Enrollment ID: I20170206000720 |
News Archive
A new study by researchers at NYU Langone Medical Center reveals that the presence of Helicobacter pylori (H. pylori) bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes.
Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.
The ability of the brain to synchronize with the tone and intonation of speech influences how language is processed. This concludes a study by the Basque research center BCBL, whose results could help design more effective activities to train the brain in order to avoid future disorders such as dyslexia.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
› Verified 2 days ago
News Archive
A new study by researchers at NYU Langone Medical Center reveals that the presence of Helicobacter pylori (H. pylori) bacteria is associated with elevated levels of glycosylated hemoglobin (HbA1c), an important biomarker for blood glucose levels and diabetes.
Plant scientists at the University of York have published the first genetic map of the medicinal herb Artemisia annua. The map is being used to accelerate plant breeding of Artemisia and rapidly develop the species into a high-yielding crop. This development is urgently needed to help meet escalating demand for effective malaria treatments.
The ability of the brain to synchronize with the tone and intonation of speech influences how language is processed. This concludes a study by the Basque research center BCBL, whose results could help design more effective activities to train the brain in order to avoid future disorders such as dyslexia.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.
Epocrates, Inc. today announced the pricing of the initial public offering of 5,360,000 shares of its common stock at a price to the public of $16.00 per share. The shares are expected to begin trading today on the NASDAQ under the ticker symbol "EPOC." Epocrates is offering 3,574,285 shares and selling stockholders are offering the remaining 1,785,715 shares.
› Verified 2 days ago
Soul Sanctuary, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1519 Forest Ave, Portland, ME 04103 Phone: 617-690-9020 | |
Catholic Charities Maine Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 307 Congress Street, Portland, ME 04101 Phone: 207-781-8550 Fax: 207-781-8560 | |
Dani Fazio Psychotherapy Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 57 Exchange St Ste 203, Portland, ME 04101 Phone: 207-618-6588 Fax: 207-203-6480 | |
Ingraham Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 50 Monument Sq, Portland, ME 04101 Phone: 207-874-1055 Fax: 207-774-5901 | |
Alliance Residential Care, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 58 Boyd St Apt 501, Portland, ME 04101 Phone: 860-710-6770 | |
Scrx-lifetransitions Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 Saint John St Ste 208, Portland, ME 04102 Phone: 207-891-8618 | |
Lauren Grousd Lcpc Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 440 Forest Ave, Portland, ME 04101 Phone: 207-650-8906 Fax: 207-221-2130 |